ABSTRACT
INTRODUCTION
Bile acids (BAs) are intestinal lipid solubilizers, facilitating uptake of fats and fat-soluble vitamins. BAs are synthesised in the liver from cholesterol, conjugated to either glycine or taurine, and stored in the gallbladder. After a meal, BAs are released into the intestine and are taken back to the liver via the superior mesenteric and the portal veins, a very efficient BA transporter system (reviewed in (Dawson et al., 2009) ). In the intestine, unconjugated BAs can diffuse passively over the intestinal border whereas conjugated forms require active transport to be taken up from the intestinal lumen. Active transport from the intestinal lumen is mediated by the apical sodium-dependent BA transporter (ASBT) in the distal ileum. Subsequently, BAs are transported over the basolateral side of the enterocyte via the organic solute transporter (OST α /OST β ) and enter the liver via the portal vein. The liver clears most BAs from the portal blood via the Na + taurocholate cotransporting polypeptide (NTCP) which is highly expressed in the liver and has a high affinity for all conjugated BA. NTCP is aided by transporters of the organic anion transporting polypeptide (OATP) family that can transport unconjugated and sulphated
BAs. In addition, it is hypothesized that the enzyme microsomal Epoxide Hydrolase (mEH) can also function as a sodium-dependent BA transporter on the sinusoidal plasma membrane (Kullak-Ublick et al., 2000) . Hepatic BAs are excreted into the biliary tract via the bile salt export pump (BSEP) on the canalicular membrane.
Most of the BAs recycle in the enterohepatic circulation and only a small amount of BAs appear in the peripheral circulation. This may have important consequences for the presumed metabolic effects of BAs that are mediated by the nuclear farnesoid X receptor (FXR) and the transmembrane Takeda G protein-coupled receptor 5 (TGR5) (Kuipers et al., 2014) . FXR regulates liver BA synthesis and metabolism, but can also contribute to glucose and lipid metabolism by stimulating the release of fibroblast growth factor (FGF) 15/19. TGR5 is not only proposed to mediate the effects of BAs on glucagon-like peptide-1 (GLP-1) and insulin release in the gut and pancreas, but also to affect energy expenditure and possibly insulin sensitivity via organs such as muscle or brown adipose tissue (Kuipers et al., 2014) . Portal vein and peripheral plasma BA concentrations peak after a meal (Angelin and Bjorkhem, 1977; LaRusso et al., 1978; Schalm et al., 1978; Angelin et al., 1982) . These observations suggest that BAs are potentially important postprandial signals to modulate metabolic and endocrine regulation in the gut, liver, muscle and fat.
Since the discovery of FXR and TGR5, it has been known that different BAs show a hierarchy in receptor activation (Parks et al., 1999; Maruyama et al., 2002; Kawamata et al., 2003; Sato et al., 2008) .
Additionally, transmembrane transport and conjugation may modulate activation patterns. Hence, porto-peripheral differences of different BA forms and their conjugation and hydrophobicity profiles may predict FXR and TGR5 activation in gut, liver and peripheral organs.
In an observational study, we investigated postprandial transhepatic BA fluxes in conscious pigs before and after a mixed meal (Figure 1 ). The pig model has been used for diabetes and metabolic research because of its resemblance to human physiology (Swindle et al., 2012) . The aim of this study was to gain more insight in the postprandial transhepatic BA fluxes and plasma profiles of the different BAs and to predict the potential relevance of BAs for FXR and TGR5 activation. In addition, we analysed human portal and peripheral vein BA profiles to translate the experimental results to relevant human data. These data illustrate that the liver selectively extracts most BAs with high TGR5 affinity, which consequently are typically low in the peripheral circulation. 
MATERIALS AND METHODS

Animals
Eleven female cross-bred pigs (20-25 kg, 8-12 weeks old) from a commercial breeder (Rosenbaum Farms, Brenham, TX) were individually housed in galvanized bar runs (2 x 3 m) enriched with straw and toys to acclimatize for 2 weeks before surgical catheter placement. They were kept on a 12 h light-dark cycle (lights on at 7 AM) with a radio turned on during the light period. Environmental temperature was 21 -25 °C. The pigs were fed 1 kg/day, Harlan-Teklad Vegetarian Pig/Sow Grower (Harlan laboratories, Indianapolis, IN). Water was available ad libitum. Data on acylcarnitines from this study have been published previously (Schooneman et al., 2015) . All animal experiments were approved by the Institutional Animal Care and Use Committee of Texas A & M University, USA.
Surgery
We placed the intravascular catheters one week before the experiment using the surgical techniques described earlier (Deutz et al., 1995; Ten Have et al., 1996) . In short, we fasted the animals for 16 h before surgery and sedated them using an intramuscular injection of tiletamine-zolazepam (3.3 mg/kg) (Telazol; Zoetis, Kalamazoo, MI). Animals were intubated and the anaesthesia continued with isoflurane (2 %). In total, we implanted 7 intravascular catheters ( Figure 1 ) as well as a feeding tube inserted percutaneously into the stomach.
In order to measure organ fluxes, we placed two catheters upstream of the organs for paraaminohippuric acid (PAH) infusion. For muscle flux measurements, we implanted the PAH infusion catheter into the abdominal aorta with its tip 5 cm above the bifurcation and the other PAH infusion catheter into the splenic vein. We inserted sampling catheters into the abdominal aorta above the right renal artery (A) for pre-organ compartment arterial plasma concentrations; into the inferior caval vein (iliac circumflex profunda vein) (V) with its tip 5 cm above the bifurcation for muscle flux measurements and venous concentrations; into the left renal vein (R) for kidney flux measurements; into the portal vein with its tip in the liver hilus (P), and into the hepatic vein (H) by direct puncture of the liver for the splanchnic measurements. To reassure that the catheter H was correctly placed in the hepatic vein, we punctured the external side of the liver and pushed in the catheter for 20 cm, then we retracted it to 5 cm to ensure we were not in the inferior caval vein. We secured all catheters in place and tunnelled them through the left abdominal wall. After abdominal closure the pigs were dressed with a canvas harness to protect the catheters. To keep the catheters patent they were filled with 0.5 mL of gentamycine (20 mg/mL) and α-chymotrypsin solution (225 U/mL).
After surgery we checked the animals twice daily for four days on body temperature, catheter patency and overall behaviour. Also, animals received i.v. injections with antibiotics (6.25 mg/kg lincomycin and 12.5 mg/kg spectinomycin) and analgetics (2 mg/kg flunixin meglumine) and the animals were allowed to recover for 7-10 days. During this period they were also habituated to the experimental cage (0.9 x 0.5 x 0.3 m on wheels).
Experimental procedure
The animals were conscious during the whole experimental procedure. We removed all food at 16:00h the day before the experiment. On the day of the experiment all animals were first weighed and at 08:00 h (t = -60 min), an hour before the meal, we started the continuous infusion of 25 mM PAH at 60 mL/h and reached steady state before the sampling started. At t = -10, -5 and 0 min, we took three baseline blood samples from all catheters. Samples were always taken in the same order during the experiment:
A, P, H, V, R. 
Sample preparation
After withdrawal, we immediately placed the blood samples on ice. For the PAH concentration measurements, we pipetted 250 μL of blood into a tube containing 25 μL of trichloroacetic acid (TCA), thoroughly vortexed, and subsequently, together with the remaining blood samples, centrifuged at 8000 g for 5 min at 4 °C. After spinning, we transferred the plasma samples into clean tubes and snap froze them in liquid nitrogen and stored them at -80 °C until further analysis. For measurements, samples were defrosted and thoroughly homogenized using a multivortex and subsequently centrifuged for 3 min at 1780 or 1800 x g and aliquoted for BA, insulin and glucose concentration measurements.
PAH concentrations and flow calculations
The PAH concentrations of the TCA plasma samples were compared to PAH standards and read out using a microplate spectrophotometer (Spectramax; Molecular Devices, Sunnyvale, CA) and SoftmaxPro software (Molecular Devices) (Agarwal, 2002) . We calculated plasma flow through the organs using the dilution of PAH over the organ compartment (Deutz et al., 1995; Ten Have et al., 1996) . Blood sampling 
Glucose and insulin concentrations
We measured glucose concentrations in duplicate with a glucose oxidase method using the Biosen C-line plus glucose analyser (EKF Diagnostics, Barleben/ Magendeburg, Germany) and insulin concentrations in duplicate with a porcine Insulin ELISA (version 4.0, Mercodia, Uppsala, Sweden) according to the manufacturer protocol. Plates were read with a spectrophotometer (Varioskan Flash version 2.4.3, Thermo Scientific) running matching SkanIt software. The calibration curve was a cubic polynomial extrapolated to concentrations of 0.01 to 2.0 ng/L. Samples outside this range were set to ≤0.01 or ≥2.0 ng/L, respectively. Insulin concentrations were not measured in renal vein samples.
BA concentrations
We measured BA concentrations by liquid chromatography-tandem mass spectrometry (LC/MS/MS, Supplemental Methods). Pigs have an abundant BA profile (Legrand-Defretin et al., 1991; Ferezou et al., 1997) . Here, we focused mainly on BAs that are prevalent in humans to enable translation:
ursodeoxycholic acid (UDCA), cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA) and hyodeoxycholic acid (HDCA, non-human), and their glycine-(g) and taurine- (t) conjugated forms. In the humans, 15 BAs were measured: UDCA, CA, CDCA, DCA and LCA and their gand t-conjugated forms. For sample preparation, after homogenizing and spinning, 25 μL plasma was aliquoted into a clean tube for BA analysis. For every 10 samples prepared, one quality control standard plasma was included. To each sample, we added 250 μL internal standard and vortexed for 60 s. Samples were centrifuged at 15800 x g and the supernatant poured into a clean glass tube. The fluid was evaporated under nitrogen at 40 °C. Before measuring samples were reconstituted in 100 μL 50 % methanol in water, vortexed for 60 s and centrifuged for 3 min at 1800 x g. We transferred the supernatant into a 0.2 μm spin-filter and centrifuged at 2,000 x g for 10 min. After filtering, the samples were transferred into LC/MS vials and analysed (10 μL injection volume). The lower limit of quantification (LOQ) was 0.05 μM for all BA forms.
In pigs, all measured concentrations of CA, tCA, gCA, DCA, gDCA and tDCA were below the LOQ.
Unconjugated UDCA concentration was never calculated due to interfering peaks in the chromatogram.
Therefore, we excluded the conjugated and unconjugated forms of CA and DCA, and unconjugated UDCA from analysis. In humans, UDCA, tUDCA and tDCA were excluded from analysis due to interfering peaks in the chromatogram. For all the other BAs, when a concentration was below the lower LOQ, its value was set to 50 % of the detection limit i.e., 0.025 μM.
Organ flux calculations
In the present model we measured organ flux through the hindquarter muscle compartment (muscle flux), the kidney compartment (renal flux), the intestine and pancreas compartment (portal drained viscera (PDV) flux) and the splanchnic compartment: the PDV plus the liver (SPL flux). We calculated liver flux as SPL flux minus PDV flux. Flux through a compartment was calculated as the mean plasma flow through that compartment multiplied with the arterio-venous difference in concentration of glucose, insulin or BA. A positive flux value is interpreted as appearance or production by the compartment, while a negative flux is interpreted as disappearance or uptake in the compartment.
Human study
We took blood samples from the cubital vein and portal vein from consecutive subjects during elective gastric by-pass surgery. Eleven healthy non-diabetic patients participated in this study (1 male, 10 females; age 46.0 ± 12.7 yrs; body mass index 41.4 ± 2.8 kg/m 2 ; mean ± SD). All participants gave informed consent before the surgery and the protocol was approved by the Medical Ethical Committee of the Academic Medical Centre and Slotervaart Hospital, Amsterdam. None of the patients used BA sequestrants. Subjects were fasted overnight prior to the surgery. First, a pre-operative peripheral venous sample was taken. During the surgery, the portal vein puncture was performed as previously described (Fontana et al., 2007) . Glucose, insulin and BA concentrations were measured in these samples.
Statistics
Calculations were made using Microsoft Excel 2010 version 14.0 and area-under-the-curve analysis and statistics were done in Graphpad Prism version 7. For porcine data analysis paired t-test or repeated measure ANOVA with Tukey post-hoc analysis were used where appropriate. For human data we used non-parametric tests. Detected numeric outliers were excluded based on Grubbs' test. Data are presented as mean ± standard error of the mean (SEM).
RESULTS
Glucose and insulin concentrations and transorgan fluxes validate the porcine model
In addition to the BAs, we measured glucose and insulin concentrations and transorgan fluxes. These 
Postprandial BA concentrations rise with large variability between animals
After the meal, BA concentrations increased in the portal vein, and, to a much lesser extent, in the peripheral circulation, with a broad peak around 1.5 to 2 hours after the meal ( Figure 3B -E, Supplemental Figure S10 ). In contrast to the relatively uniform postprandial glucose and insulin responses, these postprandial BA responses revealed relatively large inter-animal variabilities (Supplemental Figures S5-9) . When aligning the individual postprandial concentration curves at their peak a significant postprandial rise in BA concentration becomes apparent, for example for glycineconjugated hyodeoxycholic acid (gHDCA) (Supplemental Figure S11) . The most prominent BAs present in the portal vein were glycine-conjugated (g) chenodeoxycholic acid (CDCA) and gHDCA, followed by their taurine-conjugated (t) and unconjugated forms ( Figure 3E ,F). Conjugated and unconjugated forms of lithocholic acid (LCA) and ursodeoxycholic acid (UDCA) were well detected in the portal vein but their concentrations were very low elsewhere (Figure 4 ).
Porcine hepatic clearance is most efficient for conjugated CDCA forms
The BA profile in the peripheral circulation was similar to the portal vein, albeit with much lower concentrations except for gCDCA ( Figure 3 and Figure 4 ). Even though gCDCA and gHDCA were the most prominent BAs in the portal vein, hepatic vein concentrations of gCDCA were much lower than gHDCA concentrations ( Figure 3F ; ratio gHDCA:gCDCA in P: 0.95 ± 0.1 vs in V: 3.04 ± 0.3; p < 0.0001). (portal vein + aorta) . Indeed, the hepatic clearance rate of gCDCA was significantly higher than that of gHDCA (t = 60 min, p < 0.0001, Figure 3G ). In general, the hepatic clearance rates of conjugated BA were significantly higher than the clearance rates of their unconjugated forms. 
Postprandial BA exposure is high in the enterohepatic cycle compared to the peripheral circulation
Transorgan flux is different from clearance, since it is calculated by multiplying concentration difference by plasma flow. In the fasted state, BA flux in the portal vein was considerable (i.e., enterohepatic cycle).
However, after the meal transorgan fluxes doubled, in particular of the glycine-conjugated BA ( Figure   5A ). Thus, the postprandial exposure to BA in the enterohepatic circulation was high. The postprandial peak in portal BA concentrations was also clearly visible in the BA fluxes, as shown in Figure 5 . For all BAs the PDV flux was always positive with a clear postprandial peak, while the liver flux was negative and mirrored the curve of the PDV flux. These fluxes show the appearance of BA from the gut into the portal vein and the efficient absorption of BA by the liver. There was no net transorgan BAs flux over the kidneys and hindquarter (Supplemental Figure S11 ).
Peripheral exposure to the secondary BA with the highest TGR5 affinity is low
Lithocholic acid (LCA) is a secondary BA that has a high affinity for TGR5. Therefore, LCA had our special interest. In the fasted state unconjugated LCA concentration in the portal vein was approximately two times higher than gLCA and tLCA ( Figure 4A ). In general, LCA and its conjugates were detected in all portal samples, but not in all samples from other sampling sites. After the meal, portal gLCA concentration showed a robust postprandial peak, in contrast to LCA and tLCA concentrations that did not change compared to the fasted state ( Figure 4A ). PDV and liver flux curves resembled the postprandial concentration curves, although, because of the biliary secretion, the liver flux was negative ( Figure 4B ). Therefore, analogous to primary BAs, the glycine-conjugated forms increase after the ingestion of a meal. In the peripheral circulation LCA concentration was five times lower compared to the portal vein ( Figure 4A , p < 0.01). Conjugated forms of LCA were undetectable. 
Translating the porcine BA profile to humans
We translated our porcine findings to humans using portal and peripheral blood samples of patients during bariatric surgery. All subjects were obese, but none of the subjects had type 2 diabetes mellitus (mean ± standard deviation: fasting plasma glucose: 5.6 ± 0.5 mmol/L; fasting plasma insulin: 73 ± 31 pmol/L). Total BA concentrations were significantly higher in the portal vein compared to the peripheral circulation: 7.43 ± 7.2 vs 0.68 ± 0.5 μmol/L, respectively (p = 0.01). In peripheral veins BA concentrations were low and consisted of conjugated and unconjugated forms ( Figure 6 ). Portal BA concentrations were high and consisted mainly of conjugated forms, whereas the concentrations of unconjugated BAs were similar to those in the periphery ( Figure 6 ). Similar to pigs, LCA and conjugates were only detected in the portal vein. However, the human BA profile contained another secondary BA, i.e., deoxycholic acid (DCA), that circulated in the portal vein and the periphery and has been associated to insulin sensitivity (Brufau et al., 2010; Cariou et al., 2011; Haeusler et al., 2013) . 
DISCUSSION
The aim of this study was to quantify porto-peripheral postprandial plasma BA profiles and transorgan flux. Fasting and postprandial peripheral and portal BA concentrations and fluxes are substantial which is supported by the enterohepatic cycle turnover of 12 times per day (Mok et al., 1977; Lefebvre et al., 2009 ). Physiological cycling of the BA pool may have advantages. In general, metabolic or endocrine cycles enable rapid physiological adaptations when demanded. In the case of the enterohepatic cycle, continuous cycling permits a swift increase of BAs (i.e., concentration) when needed postprandially.
Continuous cycling of BA may also prevent unlimited BA synthesis via FGF15/19 effects on CYP7A1, which is the rate-limiting enzyme of the major classical pathway in BA biosynthesis (Holt et al., 2003; Inagaki et al., 2005) . Liver and intestinal FXR KO murine models have shown that Cyp7a1 repression depends mainly on intestinal FXR activation via FGF15 (Kim et al., 2007; Kong et al., 2012) . Additionally, BAs inhibit Cyp7a1 via FXR and small heterodimer partner (SHP) in the liver (Goodwin et al., 2000; Lu et al., 2000; Kuipers et al., 2014) .
The postprandial BA curves showed a large variability. La Russo et al. found that in humans peripheral conjugated CA forms show modest intra-individual variability with respect to the time of peak, however, peak height in these subjects showed up to ~30 % variation . Steiner et al. describe in detail the intra-and inter-individual variability in daily peripheral plasma BA concentrations of 4 healthy humans (Steiner et al., 2011) . Intra-individual variability of postprandial BA curves and its determinants (e.g., gut luminal BA appearance, gut microbioma characteristics, BA transporter genotypes, BA synthetic capacity, gut motility and others) need to be investigated in future studies.
We focused on human BAs and the porcine BA profile mainly consists of CDCA and HDCA forms.
CDCA is a primary BA, whereas HDCA may be both primary (since it was detected in germ free pigs (Haslewood, 1971) ) and secondary. Notably, the concentration of the unconjugated forms was unaffected by the ingestion of a meal. So the postprandial response was mainly explained by the glycineconjugated forms of CDCA and HDCA. Differences in the postprandial response between conjugated and unconjugated BAs may be due to microbiota and the affinity of the BA forms for their transporters (Dawson et al., 2009) . We found that conjugated BAs are more efficiently cleared than their unconjugated forms, showing the high effectiveness and expression of NTCP in the liver. HDCA cannot diffuse passively and is only a substrate for OATP1, but not for NTCP, which might explain the relative lower HDCA clearance compared to CDCA forms (Hata et al., 2003) . Despite the large increase in conjugated BA flux through the enterohepatic pathway after food intake, hepatic clearance of the BAs remained stable. The unconjugated BAs flow through the enterohepatic cycle passively regardless of food status and do not appear to have an additional role in postprandial fat digestion (Hofmann, 1999) .
LCA forms have the highest TGR5 affinity, but are often ignored in humans because of their low peripheral plasma concentrations. In the pigs, we showed that unconjugated LCA outnumbered conjugated LCA forms in contrast to HDCA and CDCA forms. The unconjugated LCA can either be derived from deconjugation and transformation of CDCA, or deconjugation of gLCA or tLCA by gut bacteria (Hofmann and Hagey, 2008) . LCA was already high in fasted samples and did not show a postprandial change, again indicating ongoing cycling and deconjugation without food intake. However, gLCA showed an increase after the meal, which is likely to rely on early re-uptake of gLCA that has been excreted by the liver. The human LCA conjugation profile was very much comparable to the porcine profile enabling translation. In the enterohepatic circulation the LCA forms and concentrations are likely sufficient to signal TGR5 in intestinal L-cells or liver Kupffer cells.
The porcine BA forms, i.e., HDCA, are not found in humans, whereas pigs do not have DCA which has a relative high TGR5 affinity (Sato et al., 2008) . To speculate on the potential of the plasma bile acid pool to activate TGR5 we used a simplified method to calculate the hypothetical TGR5 activating capacity for which we used the plasma BA concentration and the published EC 50 of the BAs for TGR5 (Figure 7 ) (Sato et al., 2008) . This superficial approach does not take into account the shape and range of linearity of the concentration-activation curve and the resulting measure overestimates TGR5 activity since BA concentrations were below their EC 50 value. However, it shows that TGR5 activation potential may be much higher in the portal vein than elsewhere, most likely because concentrations are also much higher in the portal vein. Interestingly, calculated human TGR5 activation capacities were not different from pigs, whereas the pool composition is very different. This could be explained by the fact that pigs had higher concentrations of BAs, including LCA, and thus similar TGR5 signalling.
Postprandial BAs have been studied to a limited extend, however this is the most sizable study so far in terms of postprandial time points, number of animals/humans and number of individual LC/MS/MS BA analyses (Angelin et al., 1982) . We did not perform activating calculations for FXR since the necessary data are not uniformly published for this receptor (Makishima et al., 1999; Parks et al., 1999) . Alternatively, a more uniform hydrophobicity index has been used to qualify BAs, but these data are not available for all BAs (Heuman, 1989; Roda et al., 1990; Twisk et al., 1995) . In addition, FXR is located in the nucleus, which complicates the calculation of potential FXR activation with plasma BA concentrations even more.
Our study has strengths and weaknesses. The porcine model is suitable for diabetes and metabolic research because it mimics human physiology and pathophysiology in many respects (Swindle et al., 2012) . More importantly, the pig has a day-night rhythm comparable to humans, is omnivorous and its intestinal transit time and efficiency of digestion resemble that of humans (Miller and Ullrey, 1987) . In an effort to translate the porcine data to humans, we included healthy obese subjects undergoing bariatric surgery. Fasting plasma BA concentrations are not different in obese subjects despite lower postprandial concentrations (Glicksman et al., 2010; Haeusler et al., 2016) . BMI is positively correlated to total BA concentrations and markers for hepatic BA synthesis in plasma (Prinz et al., 2015; Haeusler et al., 2016) . So the human data presented in this study may alter from (postprandial) BA metabolism in lean subjects. Our speculation that TGR5 activation is greater within the entero-hepatic cycle would greatly benefit from additional measurements in the pigs such as plasma GLP-1 concentrations since intestinal TGR5 activation triggers release of GLP-1 (Jain et al., 2012) . In addition, FGF19 concentrations would be interesting to indicate activation of the FXR-FGF19 axis and its beneficial effects on liver metabolism (Jain et al., 2012) . Unfortunately, the numerous blood samples limited the amount of blood per sample. Feeding pigs via a gastric tube may have prevented a normal postprandial hedonic response, but the amount and composition of the meal still elicited a robust physiological postprandial response. Finally, animals received antimicrobial therapy peri-operatively and this may have affected BA pool composition although this has not been reported previously for the antibiotics that we used.
In conclusion, the liver selectively extracts most BAs and BAs with high TGR5 affinity are typically low in the porcine and human peripheral circulation. Our data do not preclude a role for BAs to activate TGR5 in the periphery postprandially. However, their low peripheral plasma concentrations and high interindividual variability raise questions about the magnitude of such a signal and the ultimate clinical application of TGR5 agonists if the liver is not passed (van Nierop et al., 2017) . However, when comparing the fasted state to the peak of the postprandial concentration curve (fed pigs peak) food intake caused a significant increase in the TGR5 activating potential of over 30 %. Data represent mean ± SEM.
Porcine outcomes fasted vs fed staged were tested with a one-way ANOVA and Tukey post-hoc test, * p < 0.05.
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Bile acids were separated using a XBridge TM Shield RP18 column (100 mm x 2.1 mm, 3.5 μm) equipped with a XBridge TM Shield RP18 guard column (10 mm x 2.1 mm, 3.5 μm) (Waters, Milford, MA). The mass spectrometer (MS) parameters, such as gas pressure, ion spray voltage, temperature, etc., were optimized by infusing each bile acid and the internal standards (IS) separate in a 50% MeOH solution via a Harvard pump 11 standard infusion syringe pump (Harvard Apparatus, South Natick, MA). All bile acids were detected in negative mode with the mass spectrometer source settings shown in Supplementary 
